Antibody-PROTAC Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 (RIPK2) in HER+ Cell Lines (2023)

First Author: Chan K

Attributed to: Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26434/chemrxiv-2023-97zdb

Publication URI: http://dx.doi.org/10.26434/chemrxiv-2023-97zdb

Type: Preprint